Biotech & Pharma

Biotech and Pharma refer to the commercial sectors that develop, manufacture, and market products based in the biological and chemical sciences. Multinational pharmaceutical companies have invested heavily in biotech as a potential source of new products. While some biotech products and activities are socially and ethically controversial, the biotech industry often opposes public oversight and regulation. Given its impact on public debate and public policy, especially as it blurs the lines between private enterprise and public interest, biotech’s interests must be transparent.


Biopolitical Times

In May 2017, Nature Methods published a short, peer-reviewed letter reporting on a study of off-target mutations caused by CRISPR gene-editing in mice. You might recall the (somewhat panicky) headlines along the lines of Gizmodo’s Crispr May Not Be Nearly as Precise as We Thought,” and the swift drop in CRISPR-related stock prices. There was also immediate pushback from scientists, some with clear financial interests in recuperating CRISPR’s image, who criticized the study’s small sample size,...

Aggregated News

BIOTECH HAS BEEN betting big on Crispr, the gene-editing technique that promises to snip away some of humanity’s worst diseases. But last May, a small case study suggested the much-hyped technology might actually be quite dangerous—and pop went the Crispr bubble, ...

Aggregated News

Those who do not remember the past are doomed to repeat it. And those who do not remember the sometimes...

Biopolitical Times

The direct-to-consumer (DTC) gene testing company 23andMe seems to be in a strange position. The Food and Drug Administration (FDA)...

close up of a white delete key bordered by silver

Aggregated News

The U.S. Capitol building with a cloudy sky

Aggregated News

Icon of double helix in white against a circular background of blue

Aggregated News

The letters A C T G in primary colors descend down a screen

Aggregated News